Navigation Links
Codexis Board Elects Pedro I. Mizutani, Raizen EVP, as Director
Date:7/28/2011

REDWOOD CITY, Calif., July 28, 2011 /PRNewswire/ -- Codexis, Inc. (Nasdaq: CDXS) today announced that Pedro I. Mizutani, Executive Vice President, Upstream Business, Raizen Energia Participacoes S.A, has been elected to the Codexis Board of Directors. Mr. Mizutani serves as the Board representative of Raizen, Brazil's largest sugar and ethanol producer. Raizen holds approximately 16% of Codexis' outstanding shares of common stock and is the company's largest stockholder.

"We are delighted to have Pedro Mizutani join our Board," said Alan Shaw, Ph.D., President and Chief Executive Officer. "He brings a wealth of executive experience in industrial, financial and agricultural operations, as well as an in-depth knowledge of the Brazilian fuels and sugar markets. Mr. Mizutani is widely known and respected in the Brazilian business community, and his deep industry knowledge and strategic counsel will bring immediate value to Codexis."

Mr. Mizutani joined Raizen in June 2011 and has responsibility for all upstream business (production of sugar, ethanol, and bioenergy). From 2000-2010, he was Director at Cosan Group with responsibility for all upstream production, and in 2010 was appointed CEO of Cosan Sugar and Ethanol. Cosan is one of the largest groups in Brazil, with businesses in energy, food, logistics, infrastructure and agricultural property management.

He holds a degree in production engineering from the University of Sao Paulo, an MBA from the Getulio Vargas Foundation and a post-graduate degree in finance from the Methodist University of Piracicaba. He has also attended extension courses in business management at Ohio University and the Kellogg School of Management at Northwestern University. Mr. Mizutani is a member of the Board of Directors of Cosan Group, UNICA, the Brazilian sugar trade association, and Centro de Tecnologia Canavieria, a sugarcane research center in Brazil.

Codexis is a clean technology company. Codexis develops optimized biocatalysts that make industrial processes faster, cleaner and more efficient. Codexis' technology is commercialized with leading global pharmaceutical companies and in development for advanced biofuels with shell and carbon capture. Other potential markets for the company's biocatalyst-enabled solutions include chemicals and water treatment. For more information, see www.codexis.com.

Contacts:
Media: Lyn Christenson, lyn.christenson@codexis.com, 650.421.8144 or Saskia Sidenfaden, ssidenfaden@mww.com, 212.827.3771 Investors: Henk Adriaenssens, ir@codexis.com, 650.421.8331


'/>"/>
SOURCE Codexis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Codexis Reports Second Quarter 2011 Results
2. Codexis and Chemtex to Collaborate on Sustainable Detergent Alcohols for the Household Products Market
3. Codexis to Present at the Pacific Crest and Canaccord Genuity Conferences
4. Codexis to Present at 3 Investor Conferences in June
5. Codexis Achieves Development Milestones With Teva
6. Codexis to Present at Barclays Conference
7. Codexis to Announce First Quarter 2011 Financial Results on May 5, 2011
8. Codexis Names Jacques Beaudry-Losique VP Corporate Development & Strategy
9. Codexis Announces Carbon Capture Progress at ARPA-E Summit
10. Codexis Names David Anton CTO & SVP, Process Development & Manufacturing
11. Codexis to Present at the Jefferies and Pacific Crest Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... , Aug. 15, 2017  AOTI Inc. announced today that its ... Inc., has recently opened a New York City Office in ... of its unique Topical Wound Oxygen (TWO 2 ) homecare therapy. ... Accreditation Commission for Health Care (ACHC) under the company,s DMEPOS accreditation ... ...
(Date:8/8/2017)... Israel, Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), ... today reports its financial results for the second quarter ... during the second quarter 2017 and to date: ... clinical development programs for the Company,s lead project, BL-8040: ... pivotal study with BL-8040 as novel stem cell mobilization ...
(Date:8/7/2017)... Mich. , Aug. 7, 2017 Diplomat Pharmacy, ... of Joel Saban as president, effective Aug. 7, ... Urick has decided to pursue other interests and will ... "During his tenure, Paul has served us in multiple leadership ... Specialty Pharmacy in Jun. 2015 and has provided decisive, strategic ...
Breaking Medicine Technology:
(Date:8/16/2017)... ... ... Maury Regional Health has announced a large-scale adoption of AccuVein vein visualization ... Regional Medical Center is making vein visualization part of their standard of care. , ... importantly, helps our staff members locate a vein that will provide good access to ...
(Date:8/16/2017)... ... August 16, 2017 , ... A global leader in the treatment ... clinics in all 29 Indian states—bringing the country one step closer to eliminating clubfoot ... the nonprofit organization is on track to enroll 10,000 children in the clubfoot treatment ...
(Date:8/16/2017)... ... , ... Fusion Flix Inc., a Telly Award Winning, Non Profit Corporation has ... viewers in a partnership with the Amazon Video Direct Streaming Distribution Platform. , Their ... Ray disc in 2018. Proceeds will be going to further health research. , ...
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... TopConsumerReviews.com recently ... Lab Testing . , The healthcare industry in the United States has undergone ... are the days of needing to have a doctor’s order to get a blood ...
(Date:8/16/2017)... , ... August 16, 2017 , ... First Choice ... States, named Dr. Douglas J. Harrison, as the new Medical Director of its Sienna ... new facility Medical Director of our Sienna Plantation location,” said Dr. Michael (Derek) Caraway, ...
Breaking Medicine News(10 mins):